Shares of Sarepta Therapeutics surged Tuesday morning after the company said it had been informed by the Food and Drug Administration that it could resume shipping a drug it paused sales of last week.

US stocks moved higher on Tuesday, eyeing a bid for more records as investors combed through a fresh rush of corporate ...

Analysts’ view on the stock has dramatically changed over the past few months. Currently, only 21% of the 29 analysts ...

Realty Income Corporation (NYSE:O) is one of the stocks that Jim Cramer weighed in on. When a caller asked for Cramer’s ...

"This was primarily driven by 18% growth seen from the oncology portfolio, which has done well as a result of key drugs such ...